HOPEWELL, N.J. — BeiGene, a global biotech firm that develops cancer medicines, has opened a 400,000-square-foot life sciences facility in Hopewell, a suburb of Trenton. The manufacturing and ...

California-based ImmunityBio (Nasdaq: IBRX) has entered into a collaboration and supply agreement with Sino-American biotech BeiGene (Nasdaq: BGNE; be changed to BeOne Medicines) combining the ...

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from 2025-2029, according to Technavio.

ImmunityBio has entered a supply agreement and partnership with BeiGene for conducting a confirmatory Phase III ResQ201A-NSCLC trial combining tislelizumab and Anktiva to treat advanced or ...

ImmunityBio shares were up 14% to $3.52 after the company entered into a collaboration and supply agreement with BeiGene. The two companies will conduct a confirmatory randomized Phase 3 clinical ...

With the business potentially at an important milestone, we thought we'd take a closer look at BeiGene, Ltd.'s... BeiGene stock just hit that mark, with a jump from 69 to 84 Wednesday. Is BeiGene ...

In a report released yesterday, Kelly Shi from Jefferies reiterated a Buy rating on BeiGene (ONC – Research Report), with a price target of $286.00. Kelly Shi’s rating is based on a ...